Role of Glycogen Synthase Kinase-3 in Cell Fate and Epithelial-Mesenchymal Transitions
- 1 June 2007
- journal article
- review article
- Published by S. Karger AG in Cells Tissues Organs
- Vol. 185 (1-3) , 73-84
- https://doi.org/10.1159/000101306
Abstract
Epithelial cells usually exist as sheets of immotile, tightly packed, well-coupled, polarized cells with distinct apical, basal and lateral surfaces. Remarkably, these cells can dramatically alter their morphology to become motile, fibroblast-like mesenchymal cells in a process of epithelial-mesenchymal transition (EMT). This process and the reverse, mesenchymal-epithelial transition, occur repeatedly during normal embryonic development. A phenomenon similar to physiological EMT occurs during the pathophysiological progression of some cancers. Tumours of epithelial origin, as they transform to malignancy, appear to exploit the innate plasticity of epithelial cells, with EMT conferring increased invasiveness and metastatic potential. Key to the maintenance of epithelial cell identity is the expression of E-cadherin, a protein that is required for tight intercellular adhesion along the lateral surfaces of adjacent epithelial cells. Loss of functional E-cadherin is a critical event in EMT. An important regulator of E-cadherin expression is the protein Snail, a zinc-finger transcriptional repressor. Snail contains several consensus sites for the kinase, glycogen synthase kinase-3 (GSK-3), and accumulating evidence indicates that it is a GSK-3 substrate. Phosphorylation of Snail by GSK-3 facilitates its proteasomal degradation. Conversely, inhibition of GSK-3 leads to Snail accumulation, E-cadherin downregulation, and development of EMT in cultured epithelial cells. Several signalling pathways implicated in the progression of EMT, including the Wnt and phosphoinositide 3-kinase pathways, use GSK-3 to mediate their responses. In these pathways, GSK-3’s regulation of other transcriptional effectors like β-catenin works in concert with changes in Snail to orchestrate the EMT process. This review focuses on the emerging role of GSK-3 as a modulator of cell fate and EMT in the contexts of development, in vitro cell culture and cancer.Keywords
This publication has 101 references indexed in Scilit:
- Complexity in Interpretation of Embryonic Epithelial-Mesenchymal Transition in Response to Transforming Growth Factor-β SignalingCells Tissues Organs, 2007
- Multisite Protein Kinase A and Glycogen Synthase Kinase 3β Phosphorylation Leads to Gli3 Ubiquitination by SCFβTrCPMolecular and Cellular Biology, 2006
- Sonic hedgehog Signaling Regulates Gli2 Transcriptional Activity by Suppressing Its Processing and DegradationMolecular and Cellular Biology, 2006
- The Low Density Lipoprotein Receptor-related Protein 6 Interacts with Glycogen Synthase Kinase 3 and Attenuates ActivityJournal of Biological Chemistry, 2006
- The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create itDevelopmental Dynamics, 2005
- Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcriptionThe Journal of cell biology, 2005
- THE WNT SIGNALING PATHWAY IN DEVELOPMENT AND DISEASEAnnual Review of Cell and Developmental Biology, 2004
- Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation eventBiochemical Journal, 2004
- Glycogen Synthase Kinase-3β Mutagenesis Identifies a Common Binding Domain for GBP and AxinPublished by Elsevier ,2002
- A GSK3β Phosphorylation Site in Axin Modulates Interaction with β-Catenin and Tcf-Mediated Gene ExpressionBiochemical and Biophysical Research Communications, 1999